Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis
Year: 2026
Type: preprint
Abstract: This scoping review will map and synthesize the existing evidence on thymulin in relation to inflammaging and cancer, with particular emphasis on its potential role as an immunoregulatory mediator at the intersection of chronic inflammation, immune aging, and tumor biology. The review will examine the available evidence regarding thymulin’s biological functions, its relationship with age-associated immune dysregulation and chronic low-grade inflammation, and its potential involvement in cancer-related immune responses. The review will identify and characterize the existing literature addressing thymulin in the context of aging, inflammaging, cancer development or progression, immune regulation, and related molecular and cellular pathways. Where available, evidence concerning thymulin levels, regulatory mechanisms, cellular targets, signaling pathways, and associations with clinical or biological outcomes will also be mapped. The primary objective is to provide a comprehensive overview of the current state of knowledge, identify areas of convergence and uncertainty, and highlight gaps in the literature that may guide future mechanistic and translational research. Given the emerging nature and heterogeneity of the evidence base, the review will use a scoping review methodology to characterize the breadth, nature, and distribution of available evidence rather than to estimate a pooled effect.
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7203932695
